There was no statistically significant difference between the ESR1 and CTSD expression levels in patients with Basal or Her2 breast cancer (Figure 7A); however, there was a significant (p < 0.05) negative correlation in Luminal A and Luminal B patients. This evidence concerns the gene ESR1 and breast cancer.